298 related articles for article (PubMed ID: 25122660)
1. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.
Giorgetti E; Rusmini P; Crippa V; Cristofani R; Boncoraglio A; Cicardi ME; Galbiati M; Poletti A
Hum Mol Genet; 2015 Jan; 24(1):64-75. PubMed ID: 25122660
[TBL] [Abstract][Full Text] [Related]
2. Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice.
Galbiati M; Meroni M; Boido M; Cescon M; Rusmini P; Crippa V; Cristofani R; Piccolella M; Ferrari V; Tedesco B; Casarotto E; Chierichetti M; Cozzi M; Mina F; Cicardi ME; Pedretti S; Mitro N; Caretto A; Risè P; Sala A; Lieberman AP; Bonaldo P; Pennuto M; Vercelli A; Poletti A
Neurotherapeutics; 2023 Mar; 20(2):524-545. PubMed ID: 36717478
[TBL] [Abstract][Full Text] [Related]
3. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy.
Rusmini P; Crippa V; Giorgetti E; Boncoraglio A; Cristofani R; Carra S; Poletti A
Neurobiol Aging; 2013 Nov; 34(11):2585-603. PubMed ID: 23810450
[TBL] [Abstract][Full Text] [Related]
4. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Protein Quality Control System in SBMA.
Rusmini P; Crippa V; Cristofani R; Rinaldi C; Cicardi ME; Galbiati M; Carra S; Malik B; Greensmith L; Poletti A
J Mol Neurosci; 2016 Mar; 58(3):348-64. PubMed ID: 26572535
[TBL] [Abstract][Full Text] [Related]
6. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.
Rusmini P; Bolzoni E; Crippa V; Onesto E; Sau D; Galbiati M; Piccolella M; Poletti A
Neurobiol Dis; 2010 Nov; 40(2):361-9. PubMed ID: 20621188
[TBL] [Abstract][Full Text] [Related]
7. Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy.
Cicardi ME; Cristofani R; Crippa V; Ferrari V; Tedesco B; Casarotto E; Chierichetti M; Galbiati M; Piccolella M; Messi E; Carra S; Pennuto M; Rusmini P; Poletti A
Front Endocrinol (Lausanne); 2019; 10():569. PubMed ID: 31481932
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
Baniahmad A
J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
[TBL] [Abstract][Full Text] [Related]
9. Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA.
Montie HL; Merry DE
Autophagy; 2009 Nov; 5(8):1194-7. PubMed ID: 19770590
[TBL] [Abstract][Full Text] [Related]
10. Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy.
Rusmini P; Sau D; Crippa V; Palazzolo I; Simonini F; Onesto E; Martini L; Poletti A
Neurobiol Aging; 2007 Jul; 28(7):1099-111. PubMed ID: 16781019
[TBL] [Abstract][Full Text] [Related]
11. Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy.
Dossena M; Bedini G; Rusmini P; Giorgetti E; Canazza A; Tosetti V; Salsano E; Sagnelli A; Mariotti C; Gellera C; Navone SE; Marfia G; Alessandri G; Corsi F; Parati EA; Pareyson D; Poletti A
PLoS One; 2014; 9(11):e112746. PubMed ID: 25392924
[TBL] [Abstract][Full Text] [Related]
12. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
13. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Montie HL; Cho MS; Holder L; Liu Y; Tsvetkov AS; Finkbeiner S; Merry DE
Hum Mol Genet; 2009 Jun; 18(11):1937-50. PubMed ID: 19279159
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines.
Koukourakis MI; Kakouratos C; Kalamida D; Mitrakas A; Pouliliou S; Xanthopoulou E; Papadopoulou E; Fasoulaki V; Giatromanolaki A
Anticancer Drugs; 2018 Apr; 29(4):323-333. PubMed ID: 29381490
[TBL] [Abstract][Full Text] [Related]
16. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
Cortes CJ; La Spada AR
Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
[TBL] [Abstract][Full Text] [Related]
17. Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy.
Arnold FJ; Pluciennik A; Merry DE
Sci Rep; 2019 Jan; 9(1):119. PubMed ID: 30644418
[TBL] [Abstract][Full Text] [Related]
18. The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells.
Terakawa T; Miyake H; Kumano M; Sakai I; Fujisawa M
Oncol Rep; 2010 Nov; 24(5):1395-9. PubMed ID: 20878136
[TBL] [Abstract][Full Text] [Related]
19. Androgens inhibit androgen receptor promoter activation in motor neurons.
Vismara G; Simonini F; Onesto E; Bignamini M; Miceli V; Martini L; Poletti A
Neurobiol Dis; 2009 Mar; 33(3):395-404. PubMed ID: 19100835
[TBL] [Abstract][Full Text] [Related]
20. Spinal and Bulbar Muscular Atrophy Overview.
Fischbeck KH
J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
